It employs anti-depressant effects in a model of agitated depression via the inhibition of the kynurenine pathway, the downregulation of inflammatory cytokines, and elevation in the levels of serotonin (5HT) and BDNF [178]. The gene discussed is BDNF; the disease is depressive disorder.